Trial Profile
Clinical Trials Insight: 700023735
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2007
Price :
$35
*
At a glance
- Drugs Egaptivon pegol (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Adverse reactions
- Sponsors Archemix Corporation
- 12 Jun 2007 New trial record.